Stockscreener 앱 받기
643.22
0.61%
3.93
시간 외 거래:
642.69
-0.53
-0.08%
전일 마감가:
$639.29
열려 있는:
$633.8
하루 거래량:
14.46M
Relative Volume:
0.86
시가총액:
$1.63T
수익:
$200.97B
순이익/손실:
$60.46B
주가수익비율:
27.38
EPS:
23.4909
순현금흐름:
$46.11B
1주 성능:
-3.81%
1개월 성능:
+3.70%
6개월 성능:
-16.18%
1년 성능:
-10.21%
1일 변동 폭
$628.14
$645.00
1주일 범위
$628.14
$676.00
52주 변동 폭
$479.80
$796.25
메타 플랫폼스 Stock (META) Company Profile
명칭
Meta Platforms Inc
전화
650-543-4800
주소
1 META WAY, MENLO PARK
Compare META vs GOOG, GOOGL, SPOT, DASH
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
META
Meta Platforms Inc
|
643.22 | 1.62T | 200.97B | 60.46B | 46.11B | 23.49 |
|
GOOG
Alphabet Inc
|
303.94 | 3.66T | 403.06B | 132.17B | 73.27B | 10.81 |
|
GOOGL
Alphabet Inc
|
303.33 | 3.65T | 403.06B | 132.17B | 73.27B | 10.81 |
|
SPOT
Spotify Technology S A
|
477.58 | 95.26B | 19.43B | 2.56B | 3.41B | 9.6489 |
|
DASH
Doordash Inc
|
173.38 | 69.97B | 12.64B | 858.00M | 1.99B | 1.9711 |
메타 플랫폼스 Stock (META) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-01-29 | 재확인 | Canaccord Genuity | Buy |
| 2026-01-29 | 재확인 | Cantor Fitzgerald | Overweight |
| 2026-01-29 | 재확인 | Deutsche Bank | Buy |
| 2026-01-29 | 재확인 | Evercore ISI | Outperform |
| 2026-01-29 | 재확인 | Guggenheim | Buy |
| 2026-01-29 | 재확인 | JP Morgan | Overweight |
| 2026-01-29 | 재확인 | Jefferies | Buy |
| 2026-01-29 | 재확인 | KeyBanc Capital Markets | Overweight |
| 2026-01-29 | 재확인 | Mizuho | Outperform |
| 2026-01-29 | 재확인 | Monness Crespi & Hardt | Buy |
| 2026-01-29 | 재확인 | Morgan Stanley | Overweight |
| 2026-01-29 | 재확인 | Piper Sandler | Overweight |
| 2026-01-29 | 재확인 | Pivotal Research Group | Buy |
| 2026-01-29 | 재확인 | Robert W. Baird | Outperform |
| 2026-01-29 | 재확인 | Roth Capital | Buy |
| 2026-01-29 | 재확인 | Stifel | Buy |
| 2026-01-29 | 재확인 | UBS | Buy |
| 2026-01-29 | 재확인 | Wedbush | Outperform |
| 2026-01-29 | 재확인 | Wells Fargo | Overweight |
| 2026-01-29 | 재확인 | Wolfe Research | Outperform |
| 2026-01-26 | 재확인 | KeyBanc Capital Markets | Overweight |
| 2026-01-26 | 재확인 | Raymond James | Strong Buy |
| 2026-01-26 | 업그레이드 | Rothschild & Co Redburn | Neutral → Buy |
| 2026-01-23 | 재확인 | Stifel | Buy |
| 2026-01-13 | 재확인 | TD Cowen | Buy |
| 2026-01-12 | 재확인 | Wells Fargo | Overweight |
| 2026-01-08 | 재확인 | Cantor Fitzgerald | Overweight |
| 2026-01-08 | 재확인 | Guggenheim | Buy |
| 2025-12-04 | 업그레이드 | Arete | Neutral → Buy |
| 2025-11-24 | 개시 | BNP Paribas Exane | Outperform |
| 2025-11-10 | 다운그레이드 | Erste Group | Buy → Hold |
| 2025-10-30 | 재확인 | Barclays | Overweight |
| 2025-10-30 | 재확인 | Bernstein | Outperform |
| 2025-10-30 | 재확인 | BofA Securities | Buy |
| 2025-10-30 | 재확인 | Citigroup | Buy |
| 2025-10-30 | 재확인 | JP Morgan | Overweight |
| 2025-10-30 | 재확인 | Jefferies | Buy |
| 2025-10-30 | 재확인 | Mizuho | Outperform |
| 2025-10-30 | 재확인 | Monness Crespi & Hardt | Buy |
| 2025-10-30 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2025-10-30 | 재확인 | Piper Sandler | Overweight |
| 2025-10-30 | 재확인 | Stifel | Buy |
| 2025-10-30 | 다운그레이드 | The Benchmark Company | Buy → Hold |
| 2025-10-20 | 재확인 | Oppenheimer | Outperform |
| 2025-10-07 | 재확인 | Wells Fargo | Overweight |
| 2025-09-30 | 개시 | Mizuho | Outperform |
| 2025-07-31 | 재확인 | BMO Capital Markets | Market Perform |
| 2025-07-31 | 재확인 | Bernstein | Outperform |
| 2025-07-31 | 재확인 | BofA Securities | Buy |
| 2025-07-31 | 재확인 | Citigroup | Buy |
| 2025-07-31 | 재확인 | Citizens JMP | Mkt Outperform |
| 2025-07-31 | 재확인 | JP Morgan | Overweight |
| 2025-07-31 | 재확인 | KeyBanc Capital Markets | Overweight |
| 2025-07-31 | 재확인 | Monness Crespi & Hardt | Buy |
| 2025-07-31 | 재확인 | Morgan Stanley | Overweight |
| 2025-07-31 | 재확인 | Oppenheimer | Outperform |
| 2025-07-31 | 재확인 | Pivotal Research Group | Buy |
| 2025-07-31 | 재확인 | TD Cowen | Buy |
| 2025-07-31 | 재확인 | UBS | Buy |
| 2025-07-31 | 재확인 | Wedbush | Outperform |
| 2025-07-31 | 재확인 | Wells Fargo | Overweight |
| 2025-07-28 | 재확인 | Guggenheim | Buy |
| 2025-07-16 | 재확인 | Canaccord Genuity | Buy |
| 2025-07-03 | 업그레이드 | Needham | Underperform → Hold |
| 2025-06-26 | 재확인 | UBS | Buy |
| 2025-06-24 | 재확인 | Citigroup | Buy |
| 2025-05-01 | 재확인 | BofA Securities | Buy |
| 2025-05-01 | 재확인 | Citigroup | Buy |
| 2025-05-01 | 재확인 | Evercore ISI | Outperform |
| 2025-05-01 | 재확인 | Goldman | Buy |
| 2025-05-01 | 재확인 | Guggenheim | Buy |
| 2025-05-01 | 재확인 | JP Morgan | Overweight |
| 2025-05-01 | 재확인 | KeyBanc Capital Markets | Overweight |
| 2025-05-01 | 재확인 | MoffettNathanson | Buy |
| 2025-05-01 | 재확인 | Monness Crespi & Hardt | Buy |
| 2025-05-01 | 재확인 | Morgan Stanley | Overweight |
| 2025-05-01 | 재확인 | Oppenheimer | Outperform |
| 2025-05-01 | 재확인 | Piper Sandler | Overweight |
| 2025-05-01 | 재확인 | Pivotal Research Group | Buy |
| 2025-05-01 | 재확인 | Raymond James | Strong Buy |
| 2025-05-01 | 재확인 | Rosenblatt | Buy |
| 2025-05-01 | 재확인 | Roth Capital | Buy |
| 2025-05-01 | 재확인 | Stifel | Buy |
| 2025-05-01 | 재확인 | Truist | Buy |
| 2025-05-01 | 재확인 | UBS | Buy |
| 2025-05-01 | 재확인 | Wedbush | Outperform |
| 2025-04-14 | 재확인 | Citigroup | Buy |
| 2025-04-10 | 재확인 | Piper Sandler | Overweight |
| 2025-01-30 | 업그레이드 | The Benchmark Company | Hold → Buy |
| 2025-01-23 | 재확인 | BofA Securities | Buy |
| 2025-01-22 | 재확인 | Cantor Fitzgerald | Overweight |
| 2025-01-06 | 재확인 | Jefferies | Buy |
| 2025-01-03 | 재확인 | Wolfe Research | Outperform |
| 2024-10-31 | 재확인 | Monness Crespi & Hardt | Buy |
| 2024-10-31 | 재확인 | Pivotal Research Group | Buy |
| 2024-10-11 | 개시 | Scotiabank | Sector Perform |
| 2024-10-09 | 재확인 | Cantor Fitzgerald | Overweight |
| 2024-10-01 | 개시 | Pivotal Research Group | Buy |
| 2024-09-30 | 재확인 | Monness Crespi & Hardt | Buy |
| 2024-09-10 | 개시 | DA Davidson | Buy |
| 2024-09-05 | 개시 | Cantor Fitzgerald | Overweight |
| 2024-08-01 | 재확인 | BofA Securities | Buy |
| 2024-07-19 | 재확인 | Oppenheimer | Outperform |
| 2024-07-16 | 개시 | Wolfe Research | Outperform |
| 2024-07-10 | 재확인 | TD Cowen | Buy |
| 2024-07-08 | 재확인 | Wells Fargo | Overweight |
| 2024-07-01 | 재확인 | Raymond James | Strong Buy |
| 2024-06-12 | 재확인 | BMO Capital Markets | Market Perform |
| 2024-05-02 | 개시 | Exane BNP Paribas | Underperform |
| 2024-04-25 | 재확인 | Oppenheimer | Outperform |
| 2024-04-15 | 재확인 | Citigroup | Buy |
| 2024-04-11 | 재확인 | Piper Sandler | Overweight |
| 2024-04-08 | 재확인 | Oppenheimer | Outperform |
| 2024-04-04 | 재확인 | Jefferies | Buy |
| 2024-02-02 | 재확인 | Guggenheim | Buy |
| 2024-02-02 | 재확인 | JMP Securities | Mkt Outperform |
| 2024-02-02 | 재확인 | JP Morgan | Overweight |
| 2024-02-02 | 재확인 | KeyBanc Capital Markets | Overweight |
| 2024-02-02 | 재확인 | Mizuho | Buy |
| 2024-02-02 | 재확인 | Monness Crespi & Hardt | Buy |
| 2024-02-02 | 재확인 | Morgan Stanley | Overweight |
| 2024-02-02 | 재확인 | Oppenheimer | Outperform |
| 2024-02-02 | 재확인 | Piper Sandler | Overweight |
| 2024-02-02 | 재확인 | ROTH MKM | Buy |
| 2024-02-02 | 재확인 | Raymond James | Strong Buy |
| 2024-02-02 | 재확인 | Robert W. Baird | Outperform |
| 2024-02-02 | 재확인 | Seaport Research Partners | Buy |
| 2024-02-02 | 재확인 | Stifel | Buy |
| 2024-02-02 | 재확인 | Susquehanna | Positive |
| 2024-02-02 | 재확인 | TD Cowen | Outperform |
| 2024-02-02 | 재확인 | UBS | Buy |
| 2024-02-02 | 재확인 | Wedbush | Outperform |
| 2024-02-02 | 재확인 | Wells Fargo | Overweight |
| 2024-02-02 | 재확인 | Wolfe Research | Outperform |
| 2024-01-23 | 재확인 | Citigroup | Buy |
| 2024-01-17 | 재확인 | Piper Sandler | Overweight |
| 2024-01-17 | 재확인 | Wells Fargo | Overweight |
| 2024-01-09 | 개시 | BMO Capital Markets | Market Perform |
| 2023-12-20 | 재개 | Raymond James | Strong Buy |
| 2023-10-24 | 개시 | Seaport Research Partners | Buy |
| 2023-08-22 | 개시 | Wedbush | Outperform |
| 2023-08-01 | 재확인 | Argus | Buy |
| 2023-07-28 | 업그레이드 | China Renaissance | Hold → Buy |
| 2023-07-27 | 업그레이드 | HSBC Securities | Reduce → Hold |
| 2023-07-27 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2023-07-25 | 재확인 | Mizuho | Buy |
| 2023-07-25 | 업그레이드 | New Street | Neutral → Buy |
| 2023-07-19 | 재확인 | Jefferies | Buy |
| 2023-07-19 | 재확인 | Truist | Buy |
| 2023-07-17 | 재확인 | Credit Suisse | Outperform |
| 2023-07-17 | 재확인 | Goldman | Buy |
| 2023-07-17 | 재확인 | JMP Securities | Mkt Outperform |
| 2023-07-13 | 업그레이드 | TD Cowen | Market Perform → Outperform |
| 2023-07-12 | 재확인 | Deutsche Bank | Buy |
| 2023-06-08 | 개시 | Wells Fargo | Equal Weight |
| 2023-05-15 | 업그레이드 | Loop Capital | Hold → Buy |
| 2023-04-27 | 재확인 | Credit Suisse | Outperform |
| 2023-04-27 | 재확인 | Deutsche Bank | Buy |
| 2023-04-27 | 재확인 | Evercore ISI | Outperform |
| 2023-04-27 | 재확인 | Goldman | Buy |
| 2023-04-27 | 재확인 | Guggenheim | Buy |
| 2023-04-27 | 재확인 | JMP Securities | Mkt Outperform |
| 2023-04-27 | 재확인 | JP Morgan | Overweight |
| 2023-04-27 | 재확인 | Mizuho | Buy |
| 2023-04-27 | 재확인 | Monness Crespi & Hardt | Buy |
| 2023-04-27 | 재확인 | Morgan Stanley | Overweight |
| 2023-04-27 | 재확인 | Oppenheimer | Outperform |
| 2023-04-27 | 재확인 | Piper Sandler | Overweight |
| 2023-04-27 | 재확인 | RBC Capital Mkts | Outperform |
| 2023-04-27 | 재확인 | Raymond James | Outperform |
| 2023-04-27 | 재확인 | Robert W. Baird | Outperform |
| 2023-04-27 | 재확인 | Rosenblatt | Buy |
| 2023-04-27 | 재확인 | Stifel | Buy |
| 2023-04-27 | 재확인 | TD Cowen | Market Perform |
| 2023-04-27 | 재확인 | Truist | Buy |
| 2023-04-27 | 재확인 | Wolfe Research | Outperform |
모두보기
메타 플랫폼스 주식(META)의 최신 뉴스
Zuckerberg grilled over Meta’s youth strategy at social media addiction trial - SMH.com.au
Meta Secures More AI Chips From Nvidia For 'Superintelligence' Goals 02/19/2026 - MediaPost
Nvidia, Arm Stocks Rise Following Meta Deal - The Wall Street Journal
Mark Zuckerberg Says Instagram Is Valuable, Not Harmful, in Landmark Tech Addiction Trial - The New York Times
Mark Zuckerberg Grilled on Usage Goals, Underage Users at California Trial - The Wall Street Journal
Mark Zuckerberg testifies in landmark social media trial over teen mental health - The Guardian
Nvidia Wins Meta Deal. Its Gain Is Broadcom’s Loss. - Barron's
Zuckerberg testifies in landmark social media addiction case - MS NOW
Meta CEO Mark Zuckerberg testifies at trial accusing social media firms of addicting kids to their platforms - Pittsburgh Post-Gazette
Mark Zuckerberg faces jury in landmark trial over alleged youth harm linked to social media - Fox Business
Mark Zuckerberg set to testify in a landmark social media addition trial today. Here's what to know. - CBS News
S&P 500: Calm Market Waters Hide Fierce Undercurrents - Investing.com
Meta CEO Mark Zuckerberg set to testify in teen social media addiction suit - Yahoo Finance
Mark Zuckerberg to testify in social media addiction trial - BBC
Meta CEO to testify in high-stakes trial that could cost Big Tech billions - Fox Business
Zuckerberg to Defend Meta’s Youth Strategy at Social Media Addiction Trial - Bloomberg.com
Meta's Zuckerberg faces questioning at youth addiction trial - KSL News
Meta Begins $65 Million Election Push to Advance A.I. Agenda - The New York Times
Mark Zuckerberg to testify in landmark social media addiction trial - LiveNOW from FOX
NVIDIA Stock Rises After Multiyear Strategic Partnership With Meta - Benzinga
Mark Zuckerberg to answer claims social media fueled teen's depression - WCPO 9 Cincinnati
Zuckerberg testimony: Some users lie about age when signing up for Instagram - CNBC
Mark Zuckerberg set to testify in watershed social media trial - San Diego Union-Tribune
Meta inks deal to use millions of Nvidia’s chips in data centre build-out - Silicon Republic
Meta’s Zuckerberg to testify over claims of social media harm on kids - Euronews.com
Zuckerberg says Meta no longer designs apps to maximize screentime - Reuters
Nvidia Stock Rises After It Wins Meta Deal. Rival Broadcom’s Shares Slide. - Barron's
Meta expands AI infrastructure through partnership with NVIDIA - Yahoo Finance
How a Social Media Addiction Trial Threatens Big Tech - Bloomberg.com
Meta CEO Mark Zuckerberg to face jury in landmark social media addiction trial - Houston Public Media
Mark Zuckerberg arrives to testify in landmark social media addiction trial - CNN
Meta's multibillion-dollar Nvidia deal sends a signal the chip giant's rivals can't ignore - Proactive financial news
META & NVDA Expand Partnership with Next Gen GPUs, CPUs, and Networking - Meyka
Meta Platforms: Why Strong Money Loves It - Seeking Alpha
Meta Nvidia AI Deal Puts Valuation And Capex In Investor Focus - Yahoo Finance
Small business revolts over unexplained, catastrophic Meta bans - AFR
Meta, NVIDIA announce long-term AI infrastructure partnership - Anadolu Ajansı
Meta CEO Mark Zuckerberg to testify in social media trial - NBC Los Angeles
Meta's 'Project Lazarus' Would Resurrect The Dead 02/18/2026 - MediaPost
Meta AI Patent Recreates The Dead 02/18/2026 - MediaPost
Meta agrees to buy millions more AI chips for Nvidia, raising doubts about its in-house hardware - SiliconANGLE
Spain to investigate X, Meta and TikTok over AI child sexual abuse material - The Japan Times
Meta deepens Nvidia ties with pact for ‘millions’ of chips - The Japan Times
Zuckerberg to testify in landmark social media addiction trial - France 24
Meta wins patent for AI that could post for dead social media users - Mashable
Meta and Nvidia Renew Their Vows - The Information
Meta Builds AI Infrastructure With NVIDIA - NVIDIA Newsroom
Nvidia (NVDA) Valuation Check After Expanded Multiyear AI Infrastructure Deal With Meta Platforms - Yahoo Finance
Meta-NVIDIA ink massive multiyear deal for next-gen GPUs, standalone CPUs, and AI for WhatsApp - Mint
Meta Will Buy Millions of Nvidia Chips for AI Build-Out - The Wall Street Journal
Nvidia Announces AI Partnership With Meta Platforms - Investor's Business Daily
메타 플랫폼스 (META) 재무 분석
매출
순이익
현금흐름
주당 순 이익
3.19%
0.26%
자본화:
|
볼륨(24시간):